Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis

2008 ◽  
Vol 15 (10) ◽  
pp. 2811-2826 ◽  
Author(s):  
Sam M. Wiseman ◽  
Adrienne Melck ◽  
Hamid Masoudi ◽  
Fariba Ghaidi ◽  
Lynn Goldstein ◽  
...  
2017 ◽  
Vol 11 (1) ◽  
pp. 6-27 ◽  
Author(s):  
Dmitriy G. Beltsevich ◽  
Vladimir E. Vanushko ◽  
Pavel O. Rumiantsev ◽  
Galina A. Melnichenko ◽  
Nikolay S. Kuznetsov ◽  
...  

В представленных клинических рекомендациях обсуждаются современные подходы к диагностике и лечению дифференцированного рака щитовидной железы у взрослых. Изменения в настоящей редакции Клинических рекомендаций касаются показаний к пункционной биопсии, скринингового определения концентрации кальцитонина, унификации заключений цитологического исследования, новых подходах к послеоперационной динамической стратификации риска рецидива, показаний к супрессивной и заместительной терапии, таргетной терапии йоднегативных форм дифференцированного рака щитовидной железы.


PPAR Research ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-11 ◽  
Author(s):  
William M. Wood ◽  
Vibha Sharma ◽  
Kevin T. Bauerle ◽  
Laura A. Pike ◽  
Qiong Zhou ◽  
...  

Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPARγlevels are elevated in cells derived from ATC. Depletion of PPARγin HTh74 ATC cells resulted in decreased cell growth, cell cycle arrest and a reduction in pRb and cyclin A and B1 levels. We further showed that both flank and orthotopic thyroid tumors derived from PPARγ-depleted cells grew more slowly than PPARγ-expressing cells. When PPARγwas overexpressed in more differentiated thyroid cancer BCPAP cells which lack PPARγ, there was increased growth and raised pRb and cyclin A and B1 levels. Finally, PPARγdepletion in ATC cells decreased their invasive capacity whereas overexpression in PTC cells increased invasiveness. These data suggest that PPARγmay play a detrimental role in thyroid cancer and that targeting it therapeutically may lead to improved treatment of advanced thyroid cancer.


Thyroid ◽  
2016 ◽  
Vol 26 (3) ◽  
pp. 381-389 ◽  
Author(s):  
Trevor E. Angell ◽  
Melissa G. Lechner ◽  
Alison M. Smith ◽  
Sue E. Martin ◽  
Susan G. Groshen ◽  
...  

2020 ◽  
Vol 20 (5) ◽  
pp. 1-1
Author(s):  
Rongxin Sun ◽  
Longyan Yang ◽  
Yangping Hu ◽  
Yan Wang ◽  
Qiang  Zhang ◽  
...  

2019 ◽  
Vol 154 (4) ◽  
Author(s):  
Sevastián Medina-Ornelas ◽  
Francisco García-Pérez ◽  
Martín Granados-García

Sign in / Sign up

Export Citation Format

Share Document